Skip to main content

Table 1 Biochemical and serologic features of clinical subjects

From: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models

Subject

Age (years)

Gender

suPAR (ng/ml)

uPA (ng/ml)

Creatinine (mg/dl)

Up/UCr

MCD

36.00 ± 4.25

3 F/19 M

2.03 ± 0.18

0.44 ± 0.15

1.13 ± 0.26

7.7 ± 0.03

FSGS

56.83 ± 8.29

4 F/14 M

3.67 ± 0.17*

0.1 ± 0.02*

3.42 ± 1.41*

8.92 ± 4.12

  1. uPA urokinase-type plasminogen activator, suPAR soluble uPA receptor. * p<0.05 vs. MCD
Back to article page

Journal of Biomedical Science

ISSN: 1423-0127